The global recombinant protein market was valued at USD 2.11 Billion in 2025, driven by the increasing demand for effective drugs to treat chronic diseases across the globe. The market is expected to grow at a CAGR of 11.21% during the forecast period of 2026 and 2035, likely to attain a value of USD 6.11 Billion by 2035.
Base Year
Historical Period
Forecast Period
The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.
The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.
With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.
Compound Annual Growth Rate
11.21%
Value in USD Billion
2026-2035
*this image is indicative*
Recombinant proteins are synthesized using recombinant DNA methods, where a new gene sequence is produced and the coded protein is inserted into host organism such as bacteria, yeast, or animal cells to produce the protein. It involves gene cloning and transformation. It enables selection, expression, purification and study of the protein. Recombinant proteins are vital in medicine (for instance, insulin and monoclonal antibodies), research, industry, and agriculture because their quality is standardized, the expression level can be easily scaled up and fine-tuned according to the needs. In addition, the production can be customized depending on the specific application. It offers advantages like purity and offers advantages like cost efficiency, making it ideal for mass production.
Increased Application in Disease Management
Diseases like cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia are becoming more common, boosting the demand for recombinant proteins. Cancer is a highly common and fast-growing chronic disease among the major chronic diseases. The American Cancer Society (ACS) analysis from 2023 projected 1,958,310 and 609,820 deaths in United States, requiring effective and precise treatment alternatives to combat the condition. Recombinant proteins are also used in the treatments like such as chemotherapy, cell culture, western blot, animal cell culture, glycosylation, biotherapeutic products, and bioengineering, thereby, boosting the global market value.
Surge in Partnerships Between Leading Players to Meet Rising Recombinant Protein Market Demand
In January 2024, Nucleus Biologics, a top cell culture media provider, entered a deal with Core Biogenesis to distribute and manufacture affordable and sustainable recombinant proteins. Together, the two companies aim to work together and deliver better, cheaper reagents and media to the cell and gene therapy markets. As per the terms of agreement, Nucleus Biologics will act as a GMP manufacturer for Core Biogenesis’ recombinant proteins. Such partnerships are expected to shape the market landscape effectively, as it works to provide precise and affordable solutions to consumers.
The EMR’s report titled “Recombinant Protein Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by Region
Hormones Lead the Market Based on Product Type
Based on product type, the market can be divided into growth factor and cytokines, hormones, enzymes, antibodies, immune checkpoint proteins, and recombinant regulatory proteins, among others. The hormones segment is likely to take lead, owing to its versatility, particularly in the areas of research and innovation, including the development of therapies for diseases including diabetes. Hormones are very essential in the body involved in treatment for various diseases. Moreover, ease of intake makes it a popular alternative amongst users, affecting the market dynamics significantly.
Biotechnology Industry is Anticipated to Have Largest Market Share Based on Application
Based on application, the market is divided into therapeutic, research, biotechnology Industry. Among these biotechnology industry is expected to hold a significant market share, as it widely applies recombinant proteins at the clinical stages of designing, testing, and manufacturing new drugs. Recombinant proteins are central to the development of biopharmaceuticals and translate research successes into production that is clinically scalable.
Various regions covered in the global market report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Based on the regional analysis, North America is projected to hold largest market share in the forecast period, driven by increasing prevalence of diseases like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, among others. Growth in research and development activities between key market stakeholders and governments to meet the rising need for efficient medicine and treatment is also play a critical role in boosting market value.
The Asia Pacific region is likely to grow at a faster rate, owing to factors such as increasing healthcare expenditure, the growing biotechnology sector, and the upsurge in interest in recombinant protein therapies. For instance, in May 2023, Thermo Fisher Scientific Inc., and National Research and Innovation Agency (BRIN) entered the Memorandum of Understanding (MOU) with the aim of strengthening the Indonesian research and innovation systems and capacities. The partnership was aimed at helping and supporting country-level research and innovation institutions and their capacities towards improving scientific activity and the Indonesian economy. The collaboration can be viewed as a move towards enhancing the capacity of Indonesia to contribute and advance in the global realm of research and innovation.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis along with strategic initiatives by the key players. The major companies in the market are as follows:
Founded in 1998, this company occupies a premier position in the market dealing in protein research tools. The specific areas of expertise crafted by the company include primary antibodies and secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging reagents, among others.
Known as one of the largest biotechnology research companies, it is based in Massachusetts, United States. The company operates in different sectors, which include analytical instruments, lab supply chain services and e-business solutions, general lab equipment and services, specialty diagnostics, life science records, pharma solutions, contract development, and manufacturing organization.
This United States based company is a provider of purified proteins and reagent solutions to customers in pharmaceuticals and other specialty markets. It is also involved in protein analysis solutions, like analyzing solutions services and produces antibodies, enzymes, proteins, cell culture reagents, and others.
F. Hoffmann-La Roche Ltd. is a leading global pharmaceutical firm with a functional base in Basel, Switzerland; the firm operates in recombinant proteins, among many others. It works in different therapeutic segments, which include oncology, immunology, and infectious disease.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies in the market include Abbott, Merck KGaA, Bio-Rad Laboratories, Inc., GeneTex, Inc, Lonza Group SA, PerkinElmer Inc., Sino Biological Inc., TAKARA HOLDINGS INC., Tosoh Corporation, XENOTECH AI Pvt Ltd., and NEW ENGLAND BIOLABS, INC.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share